Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / multiple myeloma

multiple myeloma

Multi-year, 1143-patient genetic study identified unique types of multiple myeloma
Biotechnology | Diagnostics | Disease | Non-Profit Research | Therapeutics

Multi-year, 1143-patient genetic study identified unique types of multiple myeloma

On Aug. 19, 2024, an international team of scientists led by researchers from the Translational Genomics Research Institute (TGen) announced…

Read More Multi-year, 1143-patient genetic study identified unique types of multiple myelomaContinue

American Association for Cancer Research released biennial Cancer Disparities Progress Report 2024
Biotechnology | Disease | Life Science History | NIH | Oncology | Radiology | Therapeutics | Women's Health

American Association for Cancer Research released biennial Cancer Disparities Progress Report 2024

On May 15, 2024, the American Association for Cancer Research (AACR) released its biennial Cancer Disparities Progress Report…

Read More American Association for Cancer Research released biennial Cancer Disparities Progress Report 2024Continue

FDA approved first cell-based gene therapy for adult patients with multiple myeloma
FDA | Life Science History

FDA approved first cell-based gene therapy for adult patients with multiple myeloma

On Mar. 27, 2021, the FDA approved Abecma (idecabtagene vicleucel), a cell-based gene therapy to treat adult patients…

Read More FDA approved first cell-based gene therapy for adult patients with multiple myelomaContinue

FDA approved Bristol Myers Squibbメs and bluebird bioメs Abecma for Relapsed or Refractory Multiple Myeloma
FDA | Life Science History

FDA approved Bristol Myers Squibbメs and bluebird bioメs Abecma for Relapsed or Refractory Multiple Myeloma

On Mar. 26, 2021, Bristol Myers Squibb and bluebird bio announced that the FDA had approved Abecma (idecabtagene…

Read More FDA approved Bristol Myers Squibbメs and bluebird bioメs Abecma for Relapsed or Refractory Multiple MyelomaContinue

FDA approved DARZALEX FASPRO, a new subcutaneous formulation of Daratumumab in treatment of patients with Multiple Myeloma
Biotechnology | FDA | Therapeutics

FDA approved DARZALEX FASPRO, a new subcutaneous formulation of Daratumumab in treatment of patients with Multiple Myeloma

On May 1, 2020, Janssen Pharma, a Johnson & Johnson company, announced the U.S. Food and Drug Administration…

Read More FDA approved DARZALEX FASPRO, a new subcutaneous formulation of Daratumumab in treatment of patients with Multiple MyelomaContinue

Karyopharm to evaluate low dose Selinexor as potential treatment for hospitalized patients with COVID-19
Biotechnology | COVID-19 | FDA | Therapeutics

Karyopharm to evaluate low dose Selinexor as potential treatment for hospitalized patients with COVID-19

On Apr. 7, 2020, Karyopharm Therapeutics announced plans to initiate a global randomized clinical trial for low dose…

Read More Karyopharm to evaluate low dose Selinexor as potential treatment for hospitalized patients with COVID-19Continue

Winship Cancer Institute’s multiple myeloma team awarded $5 million grant from the Leukemia & Lymphoma Society
Biotechnology | NIH | Non-Profit Research | Oncology | Therapeutics

Winship Cancer Institute’s multiple myeloma team awarded $5 million grant from the Leukemia & Lymphoma Society

On Mar. 9, 2020, Winship Cancer Institute’s multiple myeloma team was awarded a $5 million grant from The…

Read More Winship Cancer Institute’s multiple myeloma team awarded $5 million grant from the Leukemia & Lymphoma SocietyContinue

Washington University School of Medicine gifted $20 million to boost multiple myeloma research
Life Science History

Washington University School of Medicine gifted $20 million to boost multiple myeloma research

On Nov. 29, 2018, St. Louis native Rodger Riney and his wife, Paula, donated $20 million to research…

Read More Washington University School of Medicine gifted $20 million to boost multiple myeloma researchContinue

Celgene, Dana-Farber, and University of Arkansas established the Myeloma Genome Project
Biotechnology | Diagnostics | Disease | Genomics | Medicine | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics

Celgene, Dana-Farber, and University of Arkansas established the Myeloma Genome Project

On Dec. 3, 2016, Celgene, Dana-Farber Cancer Institute and the University of Arkansas for Medical Sciences announced the…

Read More Celgene, Dana-Farber, and University of Arkansas established the Myeloma Genome ProjectContinue

Siteman Cancer Center performed its 5,000th bone marrow transplant
Disease | Life Science History | Medicine | Non-Profit Research | Oncology | Radiology | Therapeutics

Siteman Cancer Center performed its 5,000th bone marrow transplant

On Aug. 9,  2011, the Siteman Cancer Center announced that it had performed its 5,000th bone marrow transplant,…

Read More Siteman Cancer Center performed its 5,000th bone marrow transplantContinue

National Cancer Institute researchers found blocking a single protein proves toxic to myeloma cells in laboratory studies
Biotechnology | Diagnostics | Oncology | Therapeutics

National Cancer Institute researchers found blocking a single protein proves toxic to myeloma cells in laboratory studies

On Jun. 22, 2008, National Cancer Institute researchers announced that cells from a blood-borne cancer called multiple myeloma…

Read More National Cancer Institute researchers found blocking a single protein proves toxic to myeloma cells in laboratory studiesContinue

The FDA approved the drug bortezomib (Velcade) for the treatment of multiple myeloma
FDA | Life Science History

The FDA approved the drug bortezomib (Velcade) for the treatment of multiple myeloma

On May 13, 2003, the FDA approved the drug bortezomib (Velcade) for the treatment of multiple myeloma. In…

Read More The FDA approved the drug bortezomib (Velcade) for the treatment of multiple myelomaContinue

The Hematologic Cancer Research Investment and Education Act Signed into Law
Biotechnology | CDC | NIH | Oncology | Therapeutics | U.S. Congress

The Hematologic Cancer Research Investment and Education Act Signed into Law

On May 14, 2002, President George W. Bush signed the Hematologic Cancer Research Investment and Education Act of…

Read More The Hematologic Cancer Research Investment and Education Act Signed into LawContinue

  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search